Related references
Note: Only part of the references are listed.Imiquimod-gemcitabine nanoparticles harness immune cells to suppress breast cancer
Bijay Singh et al.
BIOMATERIALS (2022)
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
Brecht Decraene et al.
GENES AND IMMUNITY (2022)
Immunotherapy for glioblastoma: the promise of combination strategies
Mathilde Bausart et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2022)
Design of Bio-Responsive Hyaluronic Acid-Doxorubicin Conjugates for the Local Treatment of Glioblastoma
Alessio Malfanti et al.
PHARMACEUTICS (2022)
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians
Justin T. Low et al.
NEURO-ONCOLOGY PRACTICE (2022)
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi et al.
CELL COMMUNICATION AND SIGNALING (2022)
Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities
Johannes K. Andersen et al.
CANCERS (2022)
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
Mathilde Bausart et al.
PHARMACEUTICS (2022)
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang et al.
PHARMACEUTICS (2022)
Rationally designed drug delivery systems for the local treatment of resected glioblastoma
Chiara Bastiancich et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J. Bryan Iorgulescu et al.
CLINICAL CANCER RESEARCH (2021)
Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice
Matthias Brand et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi et al.
NATURE COMMUNICATIONS (2021)
Lipid-Polyglutamate Nanoparticle Vaccine Platform
Dorien Van Lysebetten et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Doxorubicin/CpG self-assembled nanoparticles prodrug and dendritic cells co-laden hydrogel for cancer chemo-assisted immunotherapy
Afeng Yang et al.
CHEMICAL ENGINEERING JOURNAL (2021)
A dual macrophage polarizer conjugate for synergistic melanoma therapy
Marwa A. Sallam et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies
Majed Alghamdi et al.
BIOMATERIALS SCIENCE (2021)
Highway to Success-Developing Advanced Polymer Therapeutics
Marianne B. Ashford et al.
ADVANCED THERAPEUTICS (2021)
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House et al.
CLINICAL CANCER RESEARCH (2020)
Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
Stephanie Sanders et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Isaure Vanmeerbeek et al.
ONCOIMMUNOLOGY (2020)
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Tobias Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
Yongwhan Choi et al.
PHARMACEUTICS (2020)
Hyaluronic Acid Conjugates of Vorinostat and Bexarotene for Treatment of Cutaneous Malignancies
Marwa A. Sallam et al.
ADVANCED THERAPEUTICS (2020)
In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay
Daniel Schulz et al.
SCIENTIFIC REPORTS (2019)
Potent anti-tumor immunostimulatory biocompatible nanohydrogel made from DNA
Jiana Jiang et al.
NANOSCALE RESEARCH LETTERS (2019)
Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
So-Jin Park et al.
ORAL ONCOLOGY (2019)
Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine
Philipp Probst et al.
CLINICAL CANCER RESEARCH (2019)
Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype
M. D. Sorensen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies
Qiang Wang et al.
CANCER LETTERS (2018)
Boosting doxorubicin-induced immunogenic cell death by using tumor microenvironment modulating nanoparticles
Mohammad Ali Amini et al.
CANCER RESEARCH (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Microglia and macrophages in brain homeostasis and disease
Qingyun Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The CD44-Mediated Uptake of Hyaluronic Acid-Based Carriers in Macrophages
Julio M. Rios de la Rosa et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study
Renata Ursu et al.
EUROPEAN JOURNAL OF CANCER (2017)
Calreticulin is an effective immunologic adjuvant to tumor-associated antigens
Jun Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Origin, fate and dynamics of macrophages at central nervous system interfaces
Tobias Goldmann et al.
NATURE IMMUNOLOGY (2016)
Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
Dimitrios Mathios et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma
Giovanna Lollo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Interleukin-1 beta promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production
W. Sun et al.
CELL DEATH & DISEASE (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles
Abdulaziz Almalik et al.
BIOMATERIALS (2013)
Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
Yohei Mineharu et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
The brain tumor microenvironment (vol 59, pg 1169, 2011)
Nikki A. Charles et al.
GLIA (2012)
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
Dongchang Zhao et al.
CLINICAL CANCER RESEARCH (2011)
GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell Proliferation
Colleen S. Curran et al.
JOURNAL OF IMMUNOLOGY (2011)
Hyaluronan as an Immune Regulator in Human Diseases
Dianhua Jiang et al.
PHYSIOLOGICAL REVIEWS (2011)
Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
Darya Alizadeh et al.
CLINICAL CANCER RESEARCH (2010)
Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers
Alan J. Wright et al.
MOLECULAR CANCER (2010)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2
Kara A. Scheibner et al.
JOURNAL OF IMMUNOLOGY (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Successful combination of local CpG-ODN and radiotherapy in malignant glioma
YX Meng et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
TLR9 Is localized in the endoplasmic reticulum prior to stimulation
CA Leifer et al.
JOURNAL OF IMMUNOLOGY (2004)
CpG-oligonucleotides for cancer immunotherapy: Review of the literature and potential applications in malignant glioma
AF Carpentier et al.
FRONTIERS IN BIOSCIENCE (2003)
Conformational behavior of hyaluronan in relation to its physical properties as probed by molecular modeling
K Haxaire et al.
GLYCOBIOLOGY (2000)
Share Paper
